Get the Stockscreener App
0.5847
2.63%
-0.0158
Aethlon Medical Inc stock is traded at $0.5847, with a volume of 61,206.
It is down -2.63% in the last 24 hours and down -52.07% over the past month.
Aethlon Medical Inc is a medical therapeutic company focused on developing the Hemopurifier (HP), a clinical-stage investigational immunotherapeutic device designed to address unmet needs in oncology, life-threatening infectious diseases, organ transplantation and other disease states in which extracellular vesicles (EVs) contribute to disease progression. The Hemopurifier utilizes a proprietary lectin-based technology to bind and remove enveloped viruses and EVs from biological fluids. EVs have been associated with immune suppression, metastasis, and resistance to therapy in cancer, as well as progression of severe infectious diseases. The Company operates as a single reportable segment.
See More
Previous Close:
$0.6005
Open:
$0.6
24h Volume:
61,206
Relative Volume:
0.10
Market Cap:
$1.54M
Revenue:
$574.20K
Net Income/Loss:
$-7.15M
P/E Ratio:
-0.0368
EPS:
-15.8778
Net Cash Flow:
$-7.00M
1W Performance:
-9.68%
1M Performance:
-52.07%
6M Performance:
-82.17%
1Y Performance:
-56.69%
1-Day Range:
$0.58
$0.6113
1-Week Range:
$0.58
$0.64
52-Week Range:
$0.5079
$5.89
Aethlon Medical Inc Stock (AEMD) Company Profile
Name
Aethlon Medical Inc
Sector
Industry
Phone
619-941-0360
Address
11555 SORRENTO VALLEY ROAD, SUITE 203, SAN DIEGO, CA
Compare AEMD vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AEMD
Aethlon Medical Inc
|
0.5847 | 1.54M | 574.20K | -7.15M | -7.00M | -15.88 |
ABT
Abbott Laboratories
|
103.06 | 179.51B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
330.25 | 126.60B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
83.21 | 106.51B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
44.25 | 65.77B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
82.63 | 47.58B | 6.30B | 1.07B | 1.09B | 1.8406 |
Aethlon Medical Inc Stock (AEMD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-07-25 | Resumed | H.C. Wainwright | Neutral |
Aethlon Medical Inc Stock (AEMD) Latest News
AETHLON MEDICAL INC (AEMD) Stock Chart - ChartMill
Aethlon Medical at emerging growth conference: trial data and cash boost - Investing.com
AEMD: Hemopurifier shows early promise in oncology trials, with strong platform and financial position - TradingView
Aethlon Medical Reports Encouraging Hemopurifier Trial Results - t.co
Aethlon Medical (AEMD) Gains 2.39% as Stock Approaches $0.70 Resistance LevelSentiment Extreme - dars.gov.et
Aethlon Medical reports second cohort results from cancer study - Investing.com UK
Aethlon Medical (AEMD) Slides 5.4% as Pressure Mounts Near Key Support LevelEarnings Beat Stocks - dars.gov.et
Aethlon Medical advances Hemopurifier oncology study to third cohort - grafa.com
Aethlon Medical reports second cohort results from cancer study By Investing.com - Investing.com South Africa
Experimental cancer filter shows repeat immune and tumor-signal shifts in small Australian study - Stock Titan
Aethlon Medical Inc. (AEMD) Q2 2026 Earnings: Narrower Loss Exceeds ExpectationsPretax Income Report - DonanımHaber
Aethlon Medical Announces $4 Million At-the-Market Offering to Advance Cancer and Infectious Disease Therapies - Minichart
Aethlon Medical Announces July 2026 Financing Offering - TipRanks
Aethlon Medical (NASDAQ: AEMD) prices $4M follow-on at-the-market deal - Stock Titan
Aethlon Medical Raises ~$4.0 Million in Registered Offering Priced at $0.71; Maxim Group as Agent - TradingView
Aethlon Medical (AEMD) Q1 2025 earnings summary - Quartr
Aethlon Medical (AEMD) launches $0.71 unit offering registering 11.2M shares - Stock Titan
[EFFECT] AETHLON MEDICAL INC SEC Filing - Stock Titan
Aethlon Medical Inc. (AEMD) Slides 7.6% as Shares Approach Key Support LevelSell Signal Alerts - dars.gov.et
AEMDAethlon Medical Inc Latest SEC Filings - Finviz
Aethlon Medical prices $4M follow-on offering at $0.7101 - scanx.trade
Aethlon Medical prices $4M follow-on offering at $0.71 per share - Investing.com
Aethlon Medical Announces Pricing of $4.0 Million Follow-On Offering Priced At-The-Market Under NASDAQ Rules - TradingView
Aethlon Medical prices $4M follow-on stock offe... - Pluang
AEMD Q2 2026 Earnings: EPS Beat Highlights Cost Discipline Amid Pre-Revenue PhaseEarnings Preview - dars.gov.et
AEMD Q2 2026 Earnings: Narrower-than-Expected Loss Highlights Progress in Clinical PipelineSaaS Earnings Trends - DonanımHaber
Form 4 Aethlon Medical Inc For: 1 July By Investing.com - Investing.com Canada
Aethlon Medical (AEMD) director forfeits 2,182 shares to cover RSU tax - Stock Titan
Aethlon Medical (AEMD) director forfeits 2,182 shares to cover RSU tax withholding - Stock Titan
Director at Aethlon Medical (AEMD) forfeits 1,091 shares for tax withholding - Stock Titan
Form S-1/A AETHLON MEDICAL For: 1 July By Investing.com - Investing.com UK
Aethlon Medical (AEMD) updates S-1 with auditor consent, expenses - Stock Titan
Form S-1/A Aethlon Medical Inc For: 1 July By Investing.com - Investing.com Canada
Aethlon Medical (NASDAQ: AEMD) targets $4M unit offering of shares and warrants - Stock Titan
AEMD Q2 2021 Earnings Call - BigGo ファイナンス
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
Aethlon Medical (AEMD) Slides 2.22% as Support Level Nears – Key Levels in FocusImbalance Zone - dars.gov.et
Aethlon Medical (AEMD) Reveals Key Research on Long COVID and Ex - GuruFocus
Aethlon Medical study links device to Long COVID markers - Investing.com UK
Aethlon Medical reports two-fold Long COVID signal - grafa.com
Breakthrough Long COVID Biomarker Identified by Aethlon Medical (Nasdaq: AEMD) Opens Door for Hemopurifier Treatment - Investorideas.com
Biotech's Rapid Response to the 2026 Ebola Outbreak: Vaccines, Antibodies, and Therapeutics Advance - Investorideas.com
Aethlon Medical study links device to Long COVID markers By Investing.com - Investing.com Canada
Aethlon study links Long COVID vesicles to Hemopurifier capture - Stock Titan
Price to sales forward of Aethlon Medical, Inc. – NASDAQ:AEMD - TradingView
Price to earnings forward of Aethlon Medical, Inc. – NASDAQ:AEMD - TradingView
Aethlon Medical tracks Ebola outbreak, readies Hemopurifier talks - Stock Titan
From Vaccines to Therapeutics; How Biotech Is Addressing the Ebola Outbreak - TradingView
Aethlon Medical, Inc. Actuals & Estimates (NASDAQ:AEMD) - TradingView
Enterprise value to EBIT forward of Aethlon Medical, Inc. – NASDAQ:AEMD - TradingView
AEMD Forecast — Price Target — Prediction for 2027 - TradingView
Aethlon Medical Inc Stock (AEMD) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.90%
2.27%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):